See all locations for this study
Phase 2Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Sponsored by Cytokinetics

About this study

This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.

Enrolling at this location

University of Arizona Sarver Heart Center

Tucson, Arizona

I'm interested

This study also enrolls at 25 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.